Coxiella burnetii dormancy in a fatal ten-year multisystem dysfunctional illness: case report by Sukocheva, Olga Anatolyevna
CASE REPORT Open Access
Coxiella burnetii dormancy in a fatal ten-
year multisystem dysfunctional illness: case
report
Olga A. Sukocheva1,6, Jim Manavis2, Tuck-Weng Kok3*, Mark Turra4, Angelo Izzo5, Peter Blumbergs2
and Barrie P. Marmion1,4ˆ
Abstract
Background: In a previous study of a Q fever outbreak in Birmingham, our group identified a non-infective
complex of Coxiella burnetii (C.b.) antigens able to survive in the host and provoked aberrant humoral and cell-
mediated immunity responses. The study led to recognition of a possible pathogenic link between C.b. infection
and subsequent long-term post Q fever fatigue syndrome (QFS). This report presents an unusually severe case of
C.b. antigen and DNA detection in post-mortem specimens from a patient with QFS.
Case presentation: We report a 19-year old female patient who became ill with an acute unexplained febrile
encephalitis-like illness, followed by increasingly severe multisystem dysfunction and death 10 years later. During life,
extensive clinical and laboratory investigations from different disciplinary stand points failed to deliver a definitive
identification of a cause. Given the history of susceptibility to infection from birth, acute fever and the diagnosis of
“post viral syndrome”, tests for infective agents were done starting with C.b. and Legionella pneumophila. The patient
had previously visited farms a number of times. Comprehensive neuropathological assessment at the time of autopsy
had not revealed gross or microscopic abnormalities.
The aim was to extend detailed studies with the post-mortem samples and identify possible factors driving severe
disturbance of homeostasis and organ dysfunction exhibited by the course of the patient’s ten-year illness.
Immunohistochemistry for C.b. antigen and PCR for DNA were tested on paraffin embedded blocks of autopsy tissues
from brain, spleen, liver, lymph nodes (LN), bone marrow (BM), heart and lung. Standard H&E staining of brain sections
was unrevealing. Immuno-staining analysis for astrocyte cytoskeleton proteins using glial fibrillary acidic protein (GFAP)
antibodies showed a reactive morphology. Coxiella antigens were demonstrated in GFAP immuno-positive grey and
white matter astrocytes, spleen, liver, heart, BM and LN. PCR analysis (COM1/IS1111 genes) confirmed the presence of
C.b. DNA in heart, lung, spleen, liver & LN, but not in brain or BM.
Conclusion: The study revealed the persistence of C. b. cell components in various organs, including astrocytes of
the brain, in a post-infection QFS. The possible mechanisms and molecular adaptations for this alternative C.b. life
style are discussed.
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Background
Post infection fatigue syndrome has been described in
patients exposed to facultative intracellular bacteria, in-
cluding Coxiella burnetii (C.b.) - the causative agent of
Q fever, as well as viruses [1]. The highly infectious (ca.
one organism) rickettsia-like intracellular bacterium in-
fects and multiplies in macrophages. In a previous report
of a Q fever outbreak in Birmingham, our group identi-
fied a non-infective complex of C.b. antigens able to sur-
vive in the host and provoked aberrant humoral and
cell-mediated immunity responses [2, 3]. The study led
to recognition of a possible pathogenic link between in-
fection and subsequent long-term post Q fever chronic
fatigue syndrome (QFS).
We report a 19-year old female patient (coded initials
BI) who became ill with an acute unexplained febrile
encephalitis-like illness, followed by increasingly severe
multisystem dysfunction and death ten years later (in
1996). During life, extensive clinical and laboratory in-
vestigations from different disciplinary stand points
failed to deliver a definitive identification of a cause, but
descriptive diagnoses, such as post infection fatigue syn-
drome, or just before death, Behçet’s syndrome, were
proposed. During her last 10 years, BI presented with se-
vere fluctuating headaches, frequent dizziness, fever 40C+,
recurrent episodes of extensive pharyngeal ulcerations,
muscular pain, persistent fatigue, joint pains, myoclonic
seizures, quadriparesis, symptoms suggestive of menin-
gism (neck rigidity and photophobia), bulbar paralysis and
a range of gastrointestinal tract symptoms including ab-
dominal pains, nausea, diarrhoea, bloating, oesophageal
spasms as well as weight loss. It was noted that before
the “encephalitis” there had been a history of inad-
equate, slow immune resolution on contracting various
childhood infections.
At autopsy, standard histo-pathological methods re-
vealed few abnormalities gross, or microscopic - an ulcer
of the hard palate and very sparse patchy chronic inflam-
matory cell infiltration close to the atrio-ventricular
node conducting system of the heart. Levels of inflam-
matory markers such as C-reactive protein (CRP) were
within normal range, but with increased erythrocyte
sedimentation rate. The negative organ and tissue profile
was in sharp contrast to the severity of the symptomatic
effects during life that included abnormal disabling fatig-
ability, transient loss of consciousness (“blackouts”), loss
of control over electrolyte balance and unexplained tis-
sue oedema.
In view of BI’s early history of abnormal susceptibility
to infections, her acute fever and ‘encephalitic’ symp-
toms with a diagnostic label of severe “post viral infec-
tion fatigue syndrome”, we suggested that her chronic
persistent and severe multisystem disability might be an
incidental systemic side effect (“bystander damage”) of
the specialised effector mechanisms, immune mediators
and other gene products of facultative intracellular
bacteria.
A major challenge remained that despite intense and
dedicated investigative efforts from various medical sub-
disciplines it had not been possible to identify defini-
tively the factors driving the severe disturbance of
homeostasis and organ dysfunction exhibited by the
course of BI’s 10-year illness. In anticipation that a chan-
ged paradigm for post infection and related fatigue states
would eventually emerge, BI’s family had retained the
paraffin wax-embedded or fixed slices of blocks of aut-
opsy tissues from the patient’s brain, spleen, liver, lymph
nodes (LN), bone marrow (BM), heart, lung and other
organs. The post mortem samples were submitted by
the family for examination by extended techniques to
search for possible changes in the brain using immune-
cytochemical markers for astrocytes and microglia. In
the course of examining the paraffin wax-embedded tis-
sues for possible neuropathology, prior Q fever infection
was considered. BI had previously visited farms a num-
ber of times during childhood (see review [4]). Q fever
antigens or specific antibodies had not been previously
tested. This led to extended tests with staining for Q
fever antigens in the paraffin wax-embedded tissues.
This report presents the immunohistochemical and
PCR findings of C.b. antigens and DNA respectively in
several organs, including astrocytes, from the patient’s
post mortem samples and discusses the association
between persistence of the antigens, albeit non-
infective, and QFS.
Case presentation
C.b. antigen detection (Immunocytochemistry)
Post-mortem samples were collected, formalin-fixed
(4 %, v/v), and paraffin-embedded. Sections (5 μm) of
paraffin-embedded tissues were cut and mounted on
APES coated (Superfrost plus) tissue slides and de-
paraffinised according to standard protocol. Control
healthy (disease free) brain samples were collected from
car accident trauma patient and used as an adequate
standard control [5]. Slides were stained with routine
Haematoxylin and Eosin (H&E) for initial microscopic
examination. For C.b. antigen detection, sections were
pre-treated in citrate buffer (10 mM; pH 6.0) and heated
by microwave and then allowed to cool to room
temperature [5]. Antisera and negative sera were diluted
in PBS. Immuno-staining was performed on selected
slides with primary antibodies for the following markers:
(1) C.b. Phase I and II antigens (rabbit polyclonal) or
mouse Phase I monoclonal (a gift from CSL, Australia)
[2, 3]; (2) polyclonal anti-GFAP (Santa Cruz Biotechnol-
ogy); (3) monoclonal anti-lba-1 (Abcam). Negative con-
trols consisted of sections immunostained as described
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below, but instead of overnight incubation with primary
antibodies these were incubated with tris-buffered saline
only (data not shown, but available). After washes in
PBS/0.05 % Tween-20 (Fisher Scientific), sections were
incubated with 1:100 dilutions of anti-rabbit or anti-
mouse secondary antibodies conjugated to fluorescein
isothiocyanate (FITC) or phycoerythrin (PE) (Jackson
lmmunoResearch Laboratories Inc). Nuclei were stained
with Hoechst 33342 (Invitrogen). Fluorescence images
were acquired and processed using the analysis software
Olympus Soft Imaging System. For the images where
comparisons of staining intensities were made, all
images were acquired using the same attenuator and ex-
posure settings.
C.b. DNA test (PCR)
DNA target nucleic acid sequences in tissue samples were
tested by two separate PCR assays, one targeting the
27 kDa outer membrane protein (COM1) and the other
the insertion sequence (IS1111) [6]. These were tested
with the DNA extracted from 2 paraffin-embedded tissue
sections (10 mm thick) using Proteinase K 2 mg/ml, SOS
0.5 % w/v, and Qiagen (Hilden, Germany) DNA blood kit.
Samples were amplified as described previously [6]. To
minimize possible false positives, DNA extraction and
PCR were performed carefully according to guidelines de-
scribed previously [7, 8]. A PCR result was considered
negative (NEG, Table 1) when the Ct value was ≥37. In a
real time qPCR assay (quantitative PCR), the cycle thresh-
old (Ct) value is calculated to be the number of amplifica-
tion cycles required for accumulated fluorescence signals
in the reaction to exceed the background value. The
higher the Ct value, the lower is the amount of amplified
target nucleic acid sequence (Sequence Detection Systems
v2.3 software - Applied Biosystems).
Investigation of patient BI’s brain samples with
immunohistochemical staining for astrocyte and
distribution of C.b. antigen
Given the history of susceptibility to infection from
birth, the acute fever in 1986 and the diagnosis of “post
(viral) infection syndrome”, tests for infective agents
were done starting with C.b. and Legionella pneumophila
(L.p.). Patient BI had previously visited farms a number
of times. Previous comprehensive neuropathological as-
sessment at the time of autopsy in 1986 had not revealed
gross or microscopic (H & E staining) abnormalities.
The H&E examination was repeated on fresh sections of
brain from the patient and an unrelated control brain
but no abnormalities were detected (data not shown).
Immuno-peroxidase staining for glial fibrillary acidic
protein (GFAP) showed prominent immune-staining
of astrocytes and “beading” of the fibrillary processes
compared with control brain sections which did not
show such striking changes (Fig. 1a and b). Increased
GFAP immuno-staining may be seen in many condi-
tions that may be a non-specific reactive response of
the astrocytes [9, 10].
Astrocytes in the occipital cortex and subcortical white
matter from patient BI and control brain tissue were
stained using GFAP antiserum with green-fluorescent
(FITC) secondary antibodies, co-stained with Texas-red
labelled monoclonal C.b. Phase 1 antiserum [2, 3] and
viewed with confocal microscopy (Fig. 2). Astrocytes in
the white and grey matter from patient BI (Fig. 2a and c,
white and grey matter respectively) and control brain tis-
sue (Fig. 2b and d) stained with anti-GFAP (green). Spe-
cific C.b. stained red and showed co-localization (yellow)
with GFAP (green) protein (Fig. 2a). Staining with C.b.
antisera revealed C.b. antigen complex in patient’s astro-
cytes, supporting the possible involvement of Q fever in-
fection in the illness. Note that only a minority of
astrocytes contained the C.b. Phase 1 antigen complex.
C.b. antigens were also detected in cells from hippocam-
pal white matter using dual staining with anti-GFAP and
confocal microscopy (data not shown). White and grey
matter staining for C.b. was negative in a control (unin-
fected) brain. Microglia, the innate immune cells mediat-
ing inflammatory responses in the CNS [10–12] were
identified using the specific Iba-1 marker [13, 14].
Double immune-staining of the Iba-1 reactive cells with
C.b. antisera was negative (data not shown).
Distribution of C.b. antigens in other tissue samples from
patient BI
Tissue samples from several lymphoid organs and those
previously determined as targets for C.b. were further
Table 1 Quantitative PCR (qPCR) tests for C.b. DNA (IS1111a
sequence) with patient BI’s paraffin-embedded tissues were
tested in two PCR cyclers – RotorGene 1.7.73 (Corbett Research)
and Roche LightCycler 4.05 (4.0.0.23)
Patient’s post mortem specimens Ct - RotorGene Ct - LightCycler
Heart 23.34 25.65
Lung 36.37 36.46
Brain NEG NEG
Bone marrow NEG NEG
Spleen/Liver 25.15 27.08
Lymph nodes 22.47 24.80
Control spleen NEG NEG
Control brain NEG NEG
The RotorGene Ct values shown are average of duplicate tests and LightCycler
values from single tests. Non-template controls (NTC) were placed in between
the samples and were negative (Ct >37). Thick sections of the post mortem
tissues – for PCR tests - were cut with high level of precaution to minimize
possible cross contamination at the Centre for Neurological Diseases (SA
Pathology, South Australia)
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stained using specific antisera. Figures 3 and 4 show C.b.
Phase 1 LPS antigens detected in the macrophages of
the patient’s bone marrow (Fig. 3a), liver (Fig. 3b), lymph
node (Fig. 3c), spleen (Fig. 3d) and heart (Fig. 4). Strong
staining with the monoclonal antibody to C.b. Phase 1
LPS antigen was detected in both immuno-peroxidase
(see Fig. 4) and IFA reactions (data not shown). How-
ever, the pattern was markedly different to that com-
monly described in Q fever endocarditis (early or late
stage) where the valve lesions show fibrosis and calcifica-
tion in the late stage [15]. The paucity of inflammatory
cells including monocyte/macrophage lineage and the
rapid decline of infective coxiella leaving antigen LPS
complex has frequently been remarked, as are low levels
of genomic DNA [16].
C.b. DNA results
PCR tests for C.b. genomic DNA sequences (COM1 and
IS1111a genes [6]) in separate tests did not detect the
presence of specific DNA in patient BI’s brain, but
nevertheless revealed substantial C.b. DNA in heart,
lung, spleen and liver (Table 1) - in agreement with the
results found during IFA and peroxidase staining with
C.b. Phase 1 antisera (Figs. 3 and 4). PCR tests for
COM1 and IS1111a genes showed similar results but
only Ct values for the latter gene are shown in Table 1.
The negative PCR result in the brain tissues may be due
to DNA levels below the limit of detection (10–20 cop-
ies/ml, unpublished data).
Conclusions
The scope and overall interpretation of our report on
the re-evaluation of the fixed, paraffin-embedded tissue
samples taken at patient BI’s autopsy are necessarily lim-
ited by the absence of diagnostic results of any sero-
logical or other tests for candidate infective organisms at
the time of the “viral encephalitis” in 1986 (see review
[17]). Nevertheless, taken together, the extended labora-
tory tests with C.b. specific monoclonal antibodies and
PCR (COM1 and IS1111a genes) on a range of post
mortem specimens suggest that the most compelling
and coherent explanation of BI’s illness from 1986 to
1996, is one of a severe attack of primary Q fever and a
subsequent multisystem organ dysfunction with dissem-
ination of the coxiella throughout the body, ending in
1996 with cardiac and cerebral dysfunction i.e., a com-
plex, severe idiopathic illness labelled descriptively at the
time as “post (viral) infection fatigue syndrome” (PIFS).
An epidemiological and clinical association between
laboratory-confirmed primary acute Q fever infection
and a post infection fatigue syndrome was described in
1996/8 in meat workers and farmers in Australia and in
patients in the wind-borne sheep-associated Q fever out-
break in the non-occupationally exposed populations of
Fig. 1 Assessment of Patient BI and control astrocyte GFAP immune-staining in occipital cortex and occipital subcortical white matter using
peroxidase staining technique and anti-GFAP antibodies as described in Methods. a Peroxidase staining with GFAP in samples from BI occipital
cortex showing a reactive astrocyte with numerous “beaded” processes (400X). b Peroxidase staining with GFAP in BI samples from occipital
subcortical white matter showing increased GFAP immune-staining and a reactive phenotype. Representative photographs are shown
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South Birmingham UK [18, 19]. At first the post Q fever
syndrome (QFS) tended to be interpreted as a psycho-
genic response by patients to a chronic debilitating ill-
ness. Since then, however, the association has been
described in many countries. For example, an independ-
ent follow up of patients in a goat-associated Q fever
outbreak in Alberta, Canada included a patient with
severe unresolved cerebral symptoms but C.b. was not
isolated from the CNS [20]. The recent major preva-
lence (>4000 cases) of goat-associated Q fever in the
Netherlands, allowed well-controlled surveys for “post
infection fatigue syndromes” and again confirmed
prevalence of QFS and vascular complications after
an initial infection [21].
Some of the scepticism and difficulty of acceptance of
QFS may have rested on a mistaken assumption that the
model of infection with the small intracellular bacter-
ium, Coxiella burnetii, would follow a familiar set of
characteristics of invasion, bacteraemia, inflammatory
responses, finally resolution with rising antibody levels,
acquired cellular immune responses and elimination of
the invading organism [2]. Investigations of QFS by the
Q fever Research Group in Adelaide (Australia) have not
supported this simple model [2, 3]. Notably, long term
persistence in the host of various components of the
coxiella antigens shown e.g. LPS Phase I antigen, coxiella
genomic DNA sequences and low level lgG class anti-
body in the human host to C.b. Phase I & II antigens
Fig. 2 Patient BI and control brain samples from occipital cortex grey matter and occipital subcortical white matter were analysed using confocal
microscopy for presence of C.b. antigens and co-stained for GFAP. Tissues were stained with anti-GFAP primary antibodies/FITC (green)-conjugated
secondary antibodies; and co-stained with anti-C.b. primary antibodies/PE-conjugated (red) secondary antibodies as described in Material and
Methods. Hoechst (blue) was used to stain cell nuclei. Magnification was set at 400X. a BI’s occipital subcortical white matter; b control patient’s
occipital subcortical white matter; c BI’s occipital cortex grey matter; d control patient’s occipital cortex grey matter
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Fig. 3 Presence of C.b. complexes in patient BI’s lymphoid tissues were assessed using confocal immunostaining assay: a Bone marrow, b Liver, c
LNs, d Spleen. Alexa-red was used to identify CD11c (dendritic cells - only for D). C.b. specific antibody and FITC (green) secondary antibody were
used to detect presence of C.b. and Hoechst (blue) stain defines nuclei
Fig. 4 a Immuno-peroxidase staining of myocardium - close to mitral valve - with specific monoclonal antibodies for presence of C.b. antigens
X400. b Negative control
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were often present in QFS patients more than 10 years
after the original infection [3]. On the other hand, in
perplexing contrast, efforts to demonstrate consistent
presence of the readily serial cultivable coccobacilliary
form of the coxiella (small cell variant, SCV) in such
materials have mostly failed [2, 3, 18–20].
The SCV, the infectious particle, is found in the environ-
ment and is metabolically inactive. When internalized into
a cell the SCV is transformed into the metabolically active
large cell variant (LCV) [22]. The LCV develops in re-
sponse to acidification of the endosome and is associated
with the development of the parasitophorous vacuole
(PV) by the host cell that allows the organism to replicate.
There is evidence to suggest that the highly acidic PV is
regulated by the LCV and provides an excellent environ-
ment for it to grow. Further studies will be required to de-
termine the relationship of the SCV with the PV [23, 24].
In the acute phase of Q fever, C.b. SCV is widely dis-
tributed in the host but in general they do not persist as
they transition to the LCV form. In contrast non-
infective C.b. components - complexes of Phase 1 LPS,
antigens, DNA sequences or insertion elements have
been detected in PBMC, bone marrow aspirates or valve
vegetations [2, 3, 18, 19]. Such residual complexes of
coxiella cell components persisted for 12–17 years after
infection in the patients in the Birmingham UK Q fever
outbreak [3]. Despite some partial “immune” responses
the C.b. materials are not cleared and IL-2 is down-
regulated, IFN-γ responses distorted and IL-6 responses
are enhanced [25, 26]. The effect is supported by robust
ability of C.b. to interfere with pathogen-initiated apop-
tosis upon infection of mammalian cells [27, 28] and by
the activation of type IV intracellular organism effector
repertoire [29, 30].
In summary, the recorded history, clinical findings and
indices for patient BI, and the series of reports on QFS pa-
tients from the Adelaide Q fever Research Group in
Australia and Birmingham UK, support a hypothesis that
there is an association to be tested between persistence of
C.b. components - as described above - the modified
macrophage as a PV. The terms PIFS or QFS - while cor-
rectly labelling a major clinical presentation - do not do
justice to the range of different effects or multiple host
organ systems involved, particularly as illustrated in an
unusual and exceptionally severe case such as patient BI.
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